Curis, Inc.
Curis Presents CUDC-305 Preclinical Data at the AACR 100th Annual Meeting 2009
Published in Cancer Weekly, May 12th, 2009
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, announced data provided in two presentations on the Company’s Hsp90 development candidate, CUDC-305. These presentations were given by Curis scientists at the American Association for Cancer Research (AACR) 100th Annual Meeting 2009, which is being held in Denver, Colorado from April 18-22.
“The preclinical data for CUDC-305 continue to support seeking to advance the drug toward clinical testing. It has unique pharmacological properties and demonstrated efficacy in preclinical models across a diverse number of solid and hematological tumor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-05-12)
More Articles from Cancer Weekly
- American Institute of Physics
Simulated gene therapy - Advaxis, Inc.
Advaxis Applies for Approximately $1.0 Million Worth of Grants from the National Institute of Health - Angiogenesis
Researchers from Musashino University report on findings in angiogenesis - Antiretrovirals
New antiretrovirals findings from New York University published - Ardea Biosciences, Inc.
Ardea Biosciences and Bayer HealthCare Enter into Global Agreement Focused on the Development of MEK Inhibitors for the Treatment of Cancer - Array BioPharma Inc.
Array BioPharma’s ARRY-520 Demonstrates Significant Activity in Hematological and Taxane-Resistant Tumors - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
